A number of national organizations in the United States are currently coordinating efforts to deliver type 2 diabetes (hereinafter referred to as diabetes) prevention services to attempt to curb the economic and disabling physical and psychosocial effects of the disease.1,2 This effort is supported by robust evidence from the Diabetes Prevention Program (DPP) study and others,3,4,5 which showed that lifestyle modification (LSM) and/or insulin-sensitizing medications among people at high risk for diabetes can delay progression to diabetes onset. Here, INS is linked to diabetes mellitus.